{
  "id": "interleukin-ten",
  "title": "Interleukin-10",
  "lang": "en",
  "source_lang": "en",
  "summary": "Interleukin-10 is a cytokine that limits inflammatory responses, supports immune tolerance, and has context-dependent effects on immune-cell survival and activity.",
  "category": "science",
  "subcategory": "biology",
  "type": "concept",
  "aliases": [
    "IL-10",
    "Cytokine synthesis inhibitory factor",
    "CSIF"
  ],
  "generated_at": "2026-11-03",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/interleukin-ten/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/interleukin-ten/",
      "json": "https://aiwiki.page/zh/interleukin-ten.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Interleukin-10 (IL-10) is a cytokine that regulates the immune system, particularly by limiting excessive inflammation and the tissue damage it can cause. It is produced by several immune-cell populations and acts through a specific cell-surface receptor. Although commonly described as anti-inflammatory, IL-10 is not a universal suppressor of immunity: its effects depend on the responding cell, the surrounding signals, and the stage of an immune response. It also supports some antibody-producing and cytotoxic immune responses."
    },
    {
      "heading": "Discovery and molecular characteristics",
      "text": "IL-10 was initially described in 1989 as cytokine synthesis inhibitory factor, following experiments showing that products of mouse type 2 helper T cells could inhibit cytokine production by type 1 helper T cells. Subsequent research established that its sources and functions extend well beyond this original setting.\n\nIn humans, IL-10 is encoded by the IL10 gene on chromosome 1. The initial protein contains 178 amino acids, including a signal peptide that directs secretion. Removal of this signal peptide produces a mature chain of 160 amino acids. Biologically active IL-10 normally forms a homodimer: two identical protein chains associate to create the functional molecule.\n\nIL-10 gives its name to the IL-10 cytokine family, which also includes IL-19, IL-20, IL-22, IL-24, and IL-26. These cytokines share structural features and relationships among their receptor components, but do not all reproduce IL-10’s anti-inflammatory functions."
    },
    {
      "heading": "Cellular sources and regulation",
      "text": "IL-10 can be produced by cells of both innate immunity and adaptive immunity. Important sources include:\n\n- Macrophages and dendritic cells, particularly after stimulation by microbial products or inflammatory signals.\n- T cells, including several helper and regulatory populations.\n- B cells, some of which contribute to immune regulation through IL-10 production.\n- Other immune cells, under particular conditions.\n\nIL-10 production is often induced during the same response that generates inflammatory mediators. This creates a negative-feedback mechanism that can limit the magnitude or duration of inflammation. Its production is therefore not restricted to a dedicated anti-inflammatory cell lineage.\n\nAmong T cells, both regulatory T cells expressing FOXP3 and FOXP3-negative type 1 regulatory T cells can produce IL-10. Conventional effector T cells can also acquire the ability to produce it. Consequently, IL-10 expression alone does not identify a unique regulatory-cell type."
    },
    {
      "heading": "Receptor and signaling",
      "text": "The IL-10 receptor contains two different subunits, IL-10 receptor alpha and IL-10 receptor beta, encoded by IL10RA and IL10RB. IL-10 receptor alpha provides high-affinity recognition of IL-10. IL-10 receptor beta participates in signaling and is also used by other cytokine-receptor complexes.\n\nBinding of the IL-10 dimer assembles a signaling complex containing two copies of each receptor subunit. This activates the receptor-associated enzymes JAK1 and TYK2 and, principally, the transcription factor STAT3 through the JAK–STAT signaling pathway.\n\nActivated STAT3 changes gene expression, initiating programs that restrain inflammatory activity. In macrophages, these programs reduce the production of multiple inflammatory cytokines and alter responses to subsequent stimulation.\n\nSTAT3 activation is not intrinsically anti-inflammatory. Other cytokines also activate STAT3 but produce different biological effects. Receptor-specific regulation, signaling duration, and the state of the responding cell help determine the outcome."
    },
    {
      "heading": "Biological functions",
      "text": "Control of inflammatory responses\n\nIL-10 acts especially strongly on macrophages and dendritic cells. It can reduce their production of inflammatory mediators such as tumor necrosis factor, IL-1, IL-6, and IL-12.\n\nIt can also reduce aspects of antigen presentation, including expression of major histocompatibility complex class II molecules and costimulatory molecules. In many settings, IL-10 therefore limits T-cell responses indirectly by changing the activity of antigen-presenting cells, rather than simply inhibiting T cells directly.\n\nThese actions help contain collateral tissue injury during immune responses.\n\nMucosal homeostasis and tolerance\n\nIL-10 is particularly important in the intestine, where immune cells encounter large numbers of resident microorganisms and food-derived antigens. It helps maintain immune tolerance and restrains damaging inflammatory responses while allowing protective immunity to continue.\n\nExperimental mice lacking IL-10 can develop intestinal inflammation influenced by their microbial environment. This illustrates the interaction between host immune regulation and microbial exposure rather than a response determined by IL-10 alone.\n\nSupport of selected immune responses\n\nIL-10 can promote B-cell survival and differentiation into plasma cells, supporting antibody production under appropriate conditions. It can also enhance the survival or activity of activated CD8 T cells in some experimental and disease settings.\n\nThese effects explain why “anti-inflammatory” is useful shorthand but an incomplete description of IL-10 biology."
    },
    {
      "heading": "Infection and cancer",
      "text": "During infection, IL-10 can protect tissues from damage caused by an excessive immune response. However, the same regulatory activity can weaken antimicrobial responses and contribute to pathogen persistence. The balance depends on the pathogen, affected tissue, and timing of IL-10 production.\n\nSome viruses encode IL-10-like proteins that modify host immunity. These viral proteins differ in how closely they reproduce the functions of host IL-10.\n\nIn cancer, IL-10 likewise has context-dependent effects. It can suppress antigen-presenting-cell activity and contribute to an immunoregulatory tumor environment. In other settings, it can support antitumor CD8 T-cell responses. Its presence within a tumor does not, by itself, establish whether it is promoting or restraining tumor growth."
    },
    {
      "heading": "Human disease and therapeutic research",
      "text": "Rare, disease-causing variants affecting both copies of IL10, IL10RA, or IL10RB can impair IL-10 signaling and cause severe, very-early-onset intestinal inflammation, often beginning in infancy. These inherited disorders provide strong evidence that the pathway is essential for human intestinal immune regulation. Defects in IL10RB can also affect signaling by other cytokines that share this receptor component.\n\nIL-10 concentrations have been investigated as a biomarker in inflammatory, infectious, and malignant diseases. Interpretation is difficult because elevated IL-10 may indicate a compensatory response to inflammation rather than its cause. Measurements also vary with tissue compartment, sampling time, and disease state.\n\nTherapeutic research has examined recombinant IL-10, longer-acting formulations, localized delivery, and strategies that alter its signaling. Systemic recombinant IL-10 did not show consistent clinical benefit in trials for Crohn’s disease. Its varied cellular effects and the importance of tissue-specific delivery remain central challenges in translating its biology into treatment."
    }
  ],
  "links": [
    "cytokine",
    "immune-system",
    "inflammation",
    "gene",
    "chromosome",
    "protein",
    "innate-immunity",
    "adaptive-immunity",
    "macrophage",
    "dendritic-cell",
    "t-cell",
    "b-cell",
    "feedback",
    "regulatory-t-cell",
    "foxp3",
    "transcription-factor",
    "jak-stat-signaling-pathway",
    "gene-expression",
    "major-histocompatibility-complex",
    "antigen-presenting-cell",
    "immune-tolerance",
    "plasma-cell",
    "antibody",
    "cancer",
    "biomarker"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}